Docter , Institute of High Energy Physics,Chinese Academy of Sciences , China
Dr. Juan Li 👩🔬 is an Associate Professor and Principal Investigator at the Institute of High Energy Physics (IHEP), Chinese Academy of Sciences 🏛️. With a Ph.D. in Applied Chemistry 🎓, she has emerged as a leader in nanobiotechnology, focusing on the biosafety and biomedical applications of nanomaterials 🔬. She actively contributes to national and international research projects 🌐 and serves as Editor-in-Chief of Diseases & Research 📘. Passionate about innovation in nano-enabled cancer therapy and drug delivery 💊, Dr. Li has earned a stellar reputation for her interdisciplinary work in nanomedicine and toxicology 🧪.
Professional Profile:
ORCID
Education & Experience :
Dr. Li earned her Ph.D. in Applied Chemistry from the Beijing Institute of Technology (2009) 🎓, followed by postdoctoral research at IHEP, CAS (2009–2011) 🧪. In 2019, she was a visiting scholar at UCLA 🌍. Now a tenured Associate Professor at IHEP 👩🏫, she leads critical nanomedicine projects and serves in several scientific societies 🧫. Her broad academic journey combines chemistry, physics, and biomedical research, giving her a unique edge in multidisciplinary science. Dr. Li is also involved in national-level grant projects and international collaboration 🤝, further solidifying her global impact.
Professional Development :
Dr. Juan Li has cultivated an exceptional academic profile through her roles as a Principal Investigator, council member, and scientific editor 🧠📚. Her leadership at the Key Laboratory of Nanobiological Effects and Safety, CAS ensures she stays at the forefront of nanomedicine innovation 🧬. She plays a critical role in national funding programs (NSFC, CAS Talent Program) 💼 and provincial initiatives for smart drug delivery technologies 💊. A trusted expert in toxicity, nanorobotics, and imaging, Dr. Li frequently collaborates across disciplines, mentors young researchers 👩🏫, and champions women in STEM 🚺.
Research Focus :
Dr. Li’s research lies at the intersection of nanobiotechnology, biomedicine, and toxicology 🧪. Her work addresses nanoparticle biosafety, targeted drug delivery, and smart nanorobotics for cancer treatment 🎯. She develops nano-enabled chemo-radio-immunotherapies and explores synchrotron radiation imaging for real-time tracking of nano-drugs 🔬🧲. A pioneer in surface modification of nano-carriers, her lab investigates their biological effects and preclinical potential 🧫. Her contributions are redefining the safety standards and innovation landscape of nanomedicine 🧠. Her research falls under nanomedicine, oncology, biomedical imaging, and advanced drug delivery systems 🚀.
Awards & Honors:
Dr. Li is the Editor-in-Chief of Diseases & Research 📘 and holds leadership roles in national research organizations, including the Nano-Oncology Association and Micro/Nano Robotics Society 🧬🤖. She has secured National Natural Science Foundation of China (NSFC) grants and is part of several national R&D programs 🎓💼. Her leadership in international collaboration under the CAS International Talent Program reflects her global recognition 🌏. Though individual awards aren’t listed, her appointments and competitive grant success stand as testimony to her scientific excellence, innovation, and lasting contributions to public health and nanomedicine 🏅.
Publication Top Notes:
1. A bionic palladium metal–organic framework based on a fluorescence sensing enhancement mechanism for sensitive detection of phorate
- Journal: Nanoscale (2025)
- DOI: 10.1039/D4NR03779K
- Authors: Li, Mengyao; Wang, Zhijie; Tang, Hongyu; Yang, Jingru; Luo, Xianwei; Tian, Youjia; Yang, Mingxin; Jiang, Jinhong; Wang, Meng; Zheng, Lingna; et al.
- Citations: Not yet indexed
- Key Points:
• Developed a bionic Pd-MOF with enhanced fluorescence sensing capability
• Achieved ultra-sensitive detection of the pesticide phorate
• Demonstrates strong potential for environmental monitoring and food safety
2. Magnetically Driven Bionic Nanorobots Enhance Chemotherapeutic Effectiveness and Tumor Immune Response via Precise Targeting
- Journal: The Innovation (2025)
- DOI: 10.1016/J.XINN.2024.100777
- Authors: Wang, Zhijie; Wang, Chutian; Ji, Ying; Yang, Mingxin; Li, Chan; Li, Mengyao; Yang, Jingru; Tang, Hongyu; Luo, Xianwei; Hao, Haoyang; et al.
- Citations: Not yet indexed
- Key Points:
• Engineered nanorobots guided via magnetic fields for targeted chemotherapy
• Enhanced immune response and anti-tumor efficacy in preclinical models
• Featured in the flagship issue (IF ≈ 33.2)
3. Nanoparticles Drug Delivery System in Targeted Therapy of Hepatocellular Carcinoma
- Journal: Diseases & Research (2025)
- DOI: 10.54457/dr.202402007
- Authors: Xinyuan Kong; Zirui Zhang; Hongyu Tang; Yihang Chen; Juan Li; et al.
- Citations: Not yet indexed
- Key Points:
• Reviews nanoparticle-based targeted delivery systems for liver cancer
• Highlights smart carrier design and tumor targeting strategies
• Emphasizes biocompatibility and clinical translation potentials
4. Development of Immune-Regulatory Pseudo-Protein-Coated Iron Oxide Nanoparticles for Enhanced Treatment of Triple-Negative Breast Tumor
- Journal: Nanomaterials (30 June 2025)
- DOI: 10.3390/nano15131006
- Authors: Ying Ji; Juan Li; Li Ma; Zhijie Wang; Bochu Du; Hiu Yee Kwan; Zhaoxiang Bian; Chih‑Chang Chu
- Citations: Not yet indexed
- Key Points:
• Created pseudo-protein-coated iron oxide nanoparticles to regulate immune activity
• Demonstrated improved tumor targeting and therapeutic response in TNBC models
• Merges nanotechnology, drug delivery, and immunotherapy
5. A novel shockwave-driven nanomotor composite microneedle transdermal delivery system for the localized treatment of osteoporosis: a basic science study
- Journal: International Journal of Surgery (2024)
- DOI: 10.1097/JS9.0000000000001280
- Authors: Hu Fan; Liang Haojun; Xie Jing; Yuan Meng; Huang Wanxia; Lei Yinze; Li Hao; Lv Linwen; Liu Qiuyang; Zhang Junhui; et al.
- Citations: Not yet indexed
- Key Points:
• Innovated a shockwave-activated nanomotor-microneedle device for bone healing
• Achieved localized, controlled delivery to improve osteogenesis
• Presents a new paradigm in transdermal drug delivery technology.
Conclusion:
Dr. Juan Li’s groundbreaking contributions to nano-enabled cancer therapies, smart delivery systems, and her leadership in biomedical research distinctly qualify her for the Best Researcher Award. Her scientific rigor, translational focus, and impactful innovation reflect the core spirit of this prestigious recognition.